DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)" report to their offering.
The report contains in-depth information on PCR (qPCR, dPCR and other NAAT), breaking the market opportunity down by type of NAAT, instruments versus consumables, market segment, disease indication, and type of infection.
Beyond these market size and regional estimates and forecasts for both the life science (research) and diagnostic uses of PCR, the report provides an overview of PCR and other NAAT technologies, in addition to discussion of applications of NAAT in life science and clinical diagnostics.
PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) also includes financial information on deals made by PCR and other NAAT companies, including investments and financing agreements, acquisitions, collaborations, and other agreements
Market drivers and challenges in the nucleic acid amplification test market are discussed as well. Issues of growth, competition, market opportunities, regulation, reimbursement, and prospects for the future are reviewed. Some NAAT-based tests are laboratory developed tests (LDTs); the implications of this are discussed. The clinical NAAT market is driven by the need for the information generated by testing. Market changes such as the emergence of new pathogens (such as the Zika virus), or the increasing problem of antibiotic resistance, or other changes are driving the need for specific tests.
The report contains profiles of companies in the market, reflecting the wide range NAAT products and applications in both the life science PCR market and the clinical PCR market.
Key Topics Covered:
1: Executive Summary
3: Technology Trends And Innovation
4: Nucleic Acid Amplification Tests In Research And The Clinical Laboratory
5: Deals - Polymerase Chain Reaction/Nucleic Acid Amplification Test Companies
6: Market Drivers And Challenges - Nucleic Acid Amplification Test Market
7: PCR Market Analysis
8: Company Profiles
- Abbott Laboratories
- Agena Bioscience, Inc.
- Agilent Technologies, Inc.
- Alere, Inc.
- Amoy Diagnostics Co., Ltd.
- Asuragen, Inc.
- Atlas Genetics, Ltd.
- Autogenomics, Inc.
- Beckman Coulter, Inc. (A Danaher Corporation Company)
- Becton, Dickinson And Company (BD)
- Biocartis Group NV
- Biofire Diagnostics, LLC. (Acquired by bioMérieux)
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Canon Biomedical
- Eiken Chemical Co., Ltd.
- Hologic, Inc.
- Invivoscribe Technologies, Inc.
- Janssen Diagnostics (Division of Janssen Pharmaceutica NV)
- Luminex Corporation
- Mast Group
- Meridian Bioscience, Inc.
- Quantumdx Group
- Quidel, Inc.
- Qvella Corporation
- RainDance Technologies, Inc. (Acquired by Bio-Rad Laboratories)
- Siemens Healthineers
- Spartan Bioscience, Inc.
- T2 Biosystems, Inc.
- Thermo Fisher Scientific, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/4cm6w8/pcr_market_for